Rifaximin in the treatment of inflammatory bowel disease

doi:10.3748/wjg.v17.i42.4643

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 42

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4940)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

468

HTML

4308

Tables (1-1)

164

Sum=4940

Nov 14, 2011 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Nov 14, 2011; 17(42): 4643-4646
Published online Nov 14, 2011. doi: 10.3748/wjg.v17.i42.4643

Rifaximin in the treatment of inflammatory bowel disease

Mario Guslandi

Mario Guslandi, Gastroenterology Unit, S Raffaele University Hospital, 20132 Milan, Italy

Author contributions: Guslandi M contributed solely to this editorial.

Correspondence to: Mario Guslandi, Professor, Gastroenterology Unit, S Raffaele University Hospital, Via Olgettina 60, 20132 Milan, Italy. guslandi.mario@hsr.it

Telephone: +39-02-26432744 Fax: +39-02-26433491

Received: February 24, 2011
Revised: May 26, 2011
Accepted: June 2, 2011
Published online: November 14, 2011

Core Tip